We are live on
!
Find out more
Parnassus Investments Portfolio holdings
AUM
$37.4B
1-Year Est. Return
35.42%
This Fund
S&P 500
This Quarter
Est. Return
+16.02%
1 Year Est. Return
+35.42%
3 Year Est. Return
+106.24%
5 Year Est. Return
+128.96%
10 Year Est. Return
+492.3%
AUM
$25.4B
AUM Growth
+$2.4B
(+10%)
Cap. Flow
-$918M
Cap. Flow
% of AUM
-3.62%
Top 10 Holdings %
Top 10 Hldgs %
31.21%
Holding
89
New
2
Increased
26
Reduced
36
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$152M |
| 2 |
AbbVie
ABBV
|
+$139M |
| 3 |
Biogen
BIIB
|
+$88.2M |
| 4 |
CERN
Cerner Corp
CERN
|
+$85.3M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
+$65.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Starbucks
SBUX
|
+$427M |
| 2 |
Sempra
SRE
|
+$246M |
| 3 |
CELG
Celgene Corp
CELG
|
+$166M |
| 4 |
United Parcel Service
UPS
|
+$159M |
| 5 |
CVS Health
CVS
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.56% |
| 2 | Industrials | 15.18% |
| 3 | Healthcare | 14.55% |
| 4 | Financials | 10.74% |
| 5 | Consumer Staples | 7.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Novartis
NVS
$297B
| $30.9M | 0.12% |
358,572
| – | – |
|
|
AGN
77
DELISTED
Allergan plc
AGN
| $29.3M | 0.12% |
200,000
-497,182
| -71% | -$72.1M |
|
78
Cognizant
CTSH
$26B
| $28.4M | 0.11% |
391,606
| – | – |
|
79
T-Mobile US
TMUS
$190B
| $25.7M | 0.1% |
372,637
| – | – |
|
80
FedEx
FDX
$75.4B
| $23.4M | 0.09% |
128,946
| – | – |
|
|
AL
81
DELISTED
Air Lease Corp
AL
| $21.3M | 0.08% |
621,213
| – | – |
|
82
Old Dominion Freight Line
ODFL
$44.9B
| $21.1M | 0.08% |
437,703
| – | – |
|
|
BEL
83
DELISTED
Belmond Ltd.
BEL
| $19.1M | 0.08% |
765,147
-216,665
| -22% | -$5.39M |
|
84
First American
FAF
$7.58B
| $16.2M | 0.06% |
314,819
| – | – |
|
85
Adobe
ADBE
$105B
| $10.4M | 0.04% |
39,020
| – | – |
|
|
SRE.PRA
86
DELISTED
Sempra Energy 6% Mandatory Convertible Preferred Stock, Series A
SRE.PRA
| $3.7M | 0.01% |
35,000
-15,000
| -30% | -$1.53M |
|
87
Public Storage 5.15% Series F Preferred Share
PSA.PRF
$222M
| $3M | 0.01% |
121,127
| – | – |
|
88
Bristol-Myers Squibb
BMY
$132B
| – | – |
-1,900,000
| Closed | -$98.8M |
|
|
89
Sempra
SRE
$54.8B
| – | – |
-4,539,324
| Closed | -$246M |
|
Similar funds
Parnassus Investments's Q1 2019 Portfolio in Review
As of Q1 2019, Parnassus Investments held 89 positions worth $25.4B, up 10% from $23B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Parnassus Investments withdrew a net $918M in Q1 2019, closing 2 positions and reducing 36 holdings. Its most notable exit was Sempra, an estimated $246M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Parnassus Investments opened a new position in AbbVie worth $137M.
- Parnassus Investments's largest Q1 2019 buy was AbbVie: 1,700,000 shares worth $137M.
- Parnassus Investments added most to Gilead Sciences in Q1 2019, an estimated $152M increase.
- Parnassus Investments's biggest Q1 2019 reduction was Starbucks, cutting an estimated $427M.
- Parnassus Investments fully exited Sempra in Q1 2019, selling an estimated $246M.
- Parnassus Investments's ten largest holdings make up 31% of its $25.4B portfolio in Q1 2019.
- Parnassus Investments opened 2 new positions and closed 2 in Q1 2019.
- Parnassus Investments's portfolio value rose 10% quarter-over-quarter to $25.4B.
Based on Parnassus Investments's 13F filing for Q1 2019, filed 1 May 2019.